Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tse Siang Kang

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Human Mutation|October 1, 2009
Structural aspects of therapeutic enzymes to treat metabolic disordersTse Siang Kang, Raymond C Stevens
Cellular and Molecular Life Sciences : CMLS|April 16, 2009
Structural determinants of protein foldingTse Siang Kang, R Manjunatha Kini
Molecular Genetics and Metabolism Reports|August 10, 2016
Towards the development of an enzyme replacement therapy for the metabolic disorder propionic acidemiaMahnaz Darvish-Damavandi, Han Kiat Ho, Tse Siang Kang
Therapeutic Innovation & Regulatory Science|February 20, 2024
Access to Innovative Medicines: Regulation Change and Factors Associated with Drug Approval Lag in MalaysiaWan Lee Chow, Nur Afiqah Mohd Salleh, Tse Siang Kang
Biomacromolecules|August 15, 2006
Solution structures of two structural isoforms of CMrVIA chi/lambda-conotoxinTse Siang Kang, Seetharama D S Jois, R Manjunatha Kini
Thrombosis and Haemostasis|July 11, 2014
Identification and characterisation of novel inhibitors on extrinsic tenase complex from Bungarus fasciatus (banded krait) venomWan Chen, Leng Chuan Goh, Tse Siang Kang, et al.
Drug Discovery Today|August 13, 2013
Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerationsHan Kiat Ho, Angie Hui Ling Yeo, Tse Siang Kang, et al.
Molecular Genetics and Metabolism|August 2, 2011
Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of PhenylketonuriaChristineh N Sarkissian, Tse Siang Kang, Alejandra Gámez, et al.
Molecular Genetics and Metabolism|October 2, 2009
Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuriaTse Siang Kang, Lin Wang, Christineh N Sarkissian, et al.
Biochemistry|February 24, 2007
Protein folding determinants: structural features determining alternative disulfide pairing in alpha- and chi/lambda-conotoxinsTse Siang Kang, Zoran Radić, Todd T Talley, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Human Mutation|October 1, 2009
Structural aspects of therapeutic enzymes to treat metabolic disordersTse Siang Kang, Raymond C Stevens
Cellular and Molecular Life Sciences : CMLS|April 16, 2009
Structural determinants of protein foldingTse Siang Kang, R Manjunatha Kini
Molecular Genetics and Metabolism Reports|August 10, 2016
Towards the development of an enzyme replacement therapy for the metabolic disorder propionic acidemiaMahnaz Darvish-Damavandi, Han Kiat Ho, Tse Siang Kang
Therapeutic Innovation & Regulatory Science|February 20, 2024
Access to Innovative Medicines: Regulation Change and Factors Associated with Drug Approval Lag in MalaysiaWan Lee Chow, Nur Afiqah Mohd Salleh, Tse Siang Kang
Biomacromolecules|August 15, 2006
Solution structures of two structural isoforms of CMrVIA chi/lambda-conotoxinTse Siang Kang, Seetharama D S Jois, R Manjunatha Kini
Thrombosis and Haemostasis|July 11, 2014
Identification and characterisation of novel inhibitors on extrinsic tenase complex from Bungarus fasciatus (banded krait) venomWan Chen, Leng Chuan Goh, Tse Siang Kang, et al.
Drug Discovery Today|August 13, 2013
Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerationsHan Kiat Ho, Angie Hui Ling Yeo, Tse Siang Kang, et al.
Molecular Genetics and Metabolism|August 2, 2011
Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of PhenylketonuriaChristineh N Sarkissian, Tse Siang Kang, Alejandra Gámez, et al.
Molecular Genetics and Metabolism|October 2, 2009
Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuriaTse Siang Kang, Lin Wang, Christineh N Sarkissian, et al.
Biochemistry|February 24, 2007
Protein folding determinants: structural features determining alternative disulfide pairing in alpha- and chi/lambda-conotoxinsTse Siang Kang, Zoran Radić, Todd T Talley, et al.
Pageof 2